Stereotactic Body Radiotherapy For Castration-Sensitive Prostate Cancer Bone Oligometastases

被引：0
|
作者：
Fanetti, G. [1 ]
Marvaso, G. [1 ]
Rese, A. [2 ]
Ricotti, R. [1 ]
Ciardo, D. [1 ]
Rondi, E. [3 ]
Comi, S. [3 ]
Cattani, F. [3 ]
Zerini, D. [1 ]
Fodor, C. [1 ]
De Cobelli, O. [4 ]
Orecchia, R. [5 ]
Jereczek-Fossa, B. [1 ]
机构：
[1] European Inst Oncol, Div Radiat Oncol, Milan, Italy
[2] Federico II Univ Hosp, Div Radiat Oncol, Naples, Italy
[3] European Inst Oncol, Unit Med Phys, Milan, Italy
[4] European Inst Oncol, Div Urol, Milan, Italy
[5] European Inst Oncol, Dept Med Imaging & Radiat Sci, Milan, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2018年 / 127卷
关键词：
D O I：
10.1016/S0167-8140(18)31874-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1565
引用
收藏
页码：S843 / S844
页数：2
相关论文
共 50 条
  • [31] Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer
    Grkovski, Milan
    O'Donoghue, Joseph A.
    Imber, Brandon S.
    Andl, George
    Tu, Cheng
    Lafontaine, Daniel
    Schwartz, Jazmin
    Thor, Maria
    Zelefsky, Michael J.
    Humm, John L.
    Bodei, Lisa
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) : 1779 - 1787
  • [32] Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer
    MacVicar, Gary R.
    Hussain, Maha H.
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (03) : 252 - 260
  • [33] CAN LOCAL RADIOTHERAPY CONVERT METASTATIC CASTRATION-RESISTANT PROSTATE CANCER TO A CASTRATION-SENSITIVE DISEASE? A CASE REPORT
    Terrevazzi, Sara
    Niespolo, Rita Marina
    Colciago, Riccardo Ray
    Villa, Stefano Lorenzo
    Pacifico, Pietro
    Arcangeli, Stefano
    ANTICANCER RESEARCH, 2020, 40 (08) : 4592 - 4592
  • [34] Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
    Fizazi, Karim
    NamPhuong Tran
    Fein, Luis
    Matsubara, Nobuaki
    Rodriguez-Antolin, Alfredo
    Alekseev, Boris Y.
    Ozguroglu, Mustafa
    Ye, Dingwei
    Feyerabend, Susan
    Protheroe, Andrew
    De Porre, Peter
    Kheoh, Thian
    Park, Youn C.
    Todd, Mary B.
    Chi, Kim N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (04): : 352 - 360
  • [35] How We Treat Metastatic Castration-Sensitive Prostate Cancer
    Ionescu, Filip
    Zhang, Jingsong
    CANCER CONTROL, 2024, 31
  • [36] Abiraterone or Docetaxel for Castration-sensitive Metastatic Prostate Cancer? That Is the Question!
    Messina, Carlo
    Messina, Marco
    Boccardo, Francesco
    EUROPEAN UROLOGY, 2018, 73 (01) : 147 - 148
  • [37] Prostate Cancer: Developing Novel Approaches to Castration-Sensitive Disease
    Francini, Edoardo
    Taplin, Mary-Ellen
    CANCER, 2017, 123 (01) : 29 - 42
  • [38] Rezvilutamide for metastatic castration-sensitive prostate cancer: CHART trial
    Singh, Kirti
    INDIAN JOURNAL OF UROLOGY, 2023, 39 (02) : 171 - 172
  • [39] Stereotactic Body Radiotherapy for Prostate Cancer
    Henderson, D. R.
    Tree, A. C.
    van As, N. J.
    CLINICAL ONCOLOGY, 2015, 27 (05) : 270 - 279
  • [40] STEREOTACTIC BODY RADIOTHERAPY FOR PROSTATE CANCER
    Beltramo, Giancarlo
    Longo, Giovanni
    Locatelli, Cristina
    Bergantin, Achille
    Martinotti, Anna Stefania
    Ria, Francesco
    Invernizzi, Marta
    Vai, Alessandro
    Bianchi, Livia Corinna
    Maggioni, Matteo
    Dormia, Guido
    ANTICANCER RESEARCH, 2015, 35 (06) : 3642 - 3642
12345